The S&P 500 fell on Wednesday following an unexpected rise in U.S. inflation, fueling concerns about the Federal Reserve’s reluctance to lower interest rates soon. This came amid notable gains for CVS Health and Gilead Sciences, which reported strong quarterly performances.